Form 4 for KPRX KIORA PHARMACEUTICALS INC
Accepted 2024-08-15 00:00:00 ET · period of report 2024-08-14 · accession 0001372514-24-000107 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-08-15 | 2024-08-14 | KPRX | Tosca Melissa | CFO | P - Purchase | $3.21 | +2,000 | 13.6K | +17% | +$6,420 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-14 | P | A | 2,000 | $3.21 | 13,599 | D | — | — | (F1) The shares were purchased in multiple transactions at prices ranging from $3.16 to $3.26. The reported price of $3.21 represents the volume weighted average price for the reported transaction. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. |